Inventor
WYMAN PAUL ADRIAN
GB28 patents
⚠️ This page may combine multiple inventors who share the name “WYMAN PAUL ADRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SMITHKLINE BEECHAM PLC
24 patentsUS5990133ANov 23, 1999
Indole derivatives as 5-HT receptor antagonist
SMITHKLINE BEECHAM PLC89 citations95
US6423717B1Jul 23, 2002
Sulphonamide derivatives, process for their preparation, and their use as medicaments
SMITHKLINE BEECHAM PLC33 citations92
US5972937AOct 26, 1999
Heterocyclic compounds possessing 5HT2C receptor antagonist activity
SMITHKLINE BEECHAM PLC28 citations92
US5852014ADec 22, 1998
Condensed indole derivatives as 5HT4 -receptor antagonists
SMITHKLINE BEECHAM PLC26 citations92
US5801170ASep 1, 1998
Heterocyclic biphenylylamides useful as 5HT1D antagonists
SMITHKLINE BEECHAM PLC21 citations92
US5705498AJan 6, 1998
Piperidine derivatives as 5-HT4 receptor antagonists
SMITHKLINE BEECHAM PLC30 citations92
US5726187AMar 10, 1998
N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
SMITHKLINE BEECHAM PLC40 citations91
US5696129ADec 9, 1997
5-HT4 antagonists
SMITHKLINE BEECHAM PLC37 citations91
US5998409ADec 7, 1999
Condensed indole derivatives as 5HT4 -receptor antagonists
SMITHKLINE BEECHAM PLC18 citations84
US5889022AMar 30, 1999
Indole, indoline and quinoline derivatives with 5HT1D (anti-depressive) activity
SMITHKLINE BEECHAM PLC18 citations84
US6599904B2Jul 29, 2003
Sulphonamide derivatives, process for their preparation, and their use as medicaments
SMITHKLINE BEECHAM PLC14 citations83
US6159979ADec 12, 2000
Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity
SMITHKLINE BEECHAM PLC12 citations74
US5705509AJan 6, 1998
Tricyclic heterocyclic compounds as 5-HT4 receptor antagonists
SMITHKLINE BEECHAM PLC9 citations74
US6638953B2Oct 28, 2003
Indole derivatives as 5-HT receptor antagonist
SMITHKLINE BEECHAM PLC9 citations73
US5696122ADec 9, 1997
Indole and indoline derivatives as 5HT1D receptor antagonists
SMITHKLINE BEECHAM PLC16 citations72
US6391891B1May 21, 2002
Bicyclic compounds as ligands for 5-HT1 receptors
SMITHKLINE BEECHAM PLC10 citations71
US6066644AMay 23, 2000
Azaspiro derivatives with 5HT1B activity
SMITHKLINE BEECHAM PLC3 citations63
US6939891B2Sep 6, 2005
Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
SMITHKLINE BEECHAM PLC3 citations62
US6235758B1May 22, 2001
Indole derivatives as 5-HT receptor antagonist
SMITHKLINE BEECHAM PLC2 citations62
US6100272AAug 8, 2000
Tetracyclic spiro compounds as 5HT1B receptor antagonists
SMITHKLINE BEECHAM PLC2 citations62
US5972951AOct 26, 1999
Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
SMITHKLINE BEECHAM PLC6 citations62
US5952325ASep 14, 1999
Tricyclic spiro compounds process for their preparation and their use of 5HT1D receptor antagonists
SMITHKLINE BEECHAM PLC3 citations62
US6747030B1Jun 8, 2004
Piperazine derivatives as 5-HT1B antagonists
SMITHKLINE BEECHAM PLC2 citations61
US7109201B2Sep 19, 2006
Piperazine derivatives, their preparation and uses in therapy
SMITHKLINE BEECHAM PLC1 citations52
COOPER DAVID GWYN
3 patentsUS8426443B2Apr 23, 2013
Compounds which have activity at M1 receptor and their uses in medicine
COOPER DAVID GWYN0 citations45
US8278328B2Oct 2, 2012
Compounds which have activity at M1 receptor and their uses in medicine
COOPER DAVID GWYN0 citations45
US8299257B2Oct 30, 2012
Compounds which have activity at M1receptor and their uses in medicine
COOPER DAVID GWYN0 citations35